Literature DB >> 12565701

Cancer cachexia: the molecular mechanisms.

Josep M Argilés1, Rodrigo Moore-Carrasco, Gemma Fuster, Sílvia Busquets, Francisco J López-Soriano.   

Abstract

Cancer cachexia is a syndrome characterised by a marked weight loss, anorexia, asthenia and anaemia. In fact, many patients who die with advanced cancer suffer from cancer cachexia. The cachectic state is invariably associated with the presence and growth of the tumour and leads to a malnutrition status due to the induction of anorexia or decreased food intake. In addition, the competition for nutrients between the tumour and the host leads to an accelerated starvation state which promotes severe metabolic disturbances in the host, including hypermetabolism which leads to an increased energetic inefficiency. Although, the search for the cachectic factor(s) started a long time ago, and although many scientific and economic efforts have been devoted to its discovery, we are still a long way from knowing the whole truth. The main aim of the present review is to summarise and evaluate the different catabolic mediators (both humoural and tumoural) involved in cancer cachexia since they may represent targets for future promising clinical investigations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565701     DOI: 10.1016/s1357-2725(02)00251-0

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  28 in total

1.  Molecular characterization of skin microbiota between cancer cachexia patients and healthy volunteers.

Authors:  Wei Li; Lei Han; Pengbo Yu; Chaofeng Ma; Xiaokang Wu; John E Moore; Jiru Xu
Journal:  Microb Ecol       Date:  2014-01-09       Impact factor: 4.552

Review 2.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

3.  Nutrition in head and neck cancer patients.

Authors:  Prashanth Varkey; Wen-Ruay Tang; Ngian Chye Tan
Journal:  Semin Plast Surg       Date:  2010-08       Impact factor: 2.314

4.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

Review 5.  Biomarkers for cancer cachexia: is there also a genetic component to cachexia?

Authors:  B H L Tan; D A C Deans; R J E Skipworth; J A Ross; K C H Fearon
Journal:  Support Care Cancer       Date:  2007-12-11       Impact factor: 3.603

6.  Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.

Authors:  Swarnali Acharyya; Katherine J Ladner; Lori L Nelsen; Jeffrey Damrauer; Peter J Reiser; Steven Swoap; Denis C Guttridge
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

7.  Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.

Authors:  Xinxia Zhu; Michael F Callahan; Kenneth A Gruber; Marek Szumowski; Daniel L Marks
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 8.  Inflammation and cancer: advances and new agents.

Authors:  Shanthini M Crusz; Frances R Balkwill
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

9.  P-selectin genotype is associated with the development of cancer cachexia.

Authors:  Benjamin H L Tan; Torill Fladvad; Theodore P Braun; Antonio Vigano; Florian Strasser; D A Christopher Deans; Richard J E Skipworth; Tora S Solheim; Sambasivarao Damaraju; James A Ross; Stein Kaasa; Daniel L Marks; Vickie E Baracos; Frank Skorpen; Kenneth C H Fearon
Journal:  EMBO Mol Med       Date:  2012-04-04       Impact factor: 12.137

10.  Cancer cachexia: mechanisms and clinical implications.

Authors:  Claire L Donohoe; Aoife M Ryan; John V Reynolds
Journal:  Gastroenterol Res Pract       Date:  2011-06-13       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.